1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

2.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176

3.
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203...
by Peters, Sanne A. E
Diabetologia, 2014-05-25, Vol.57 (8), p.1542-1551

4.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

5.
Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects
by Muntner, Paul, PhD
The American heart journal, 2011, Vol.161 (4), p.719-725

6.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

7.
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
by Muntner, Paul, PhD
The American journal of cardiology, 2011, Vol.108 (6), p.822-827

8.
Combined Role of Reduced Estimated Glomerular Filtration Rate and Microalbuminuria on the Prevalence of Peripheral Arterial Disease
by Baber, Usman, MD
The American journal of cardiology, 2009, Vol.104 (10), p.1446-1451

9.
Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of Hypertension: The Multi-Ethnic Study of Atherosclerosis
by Muntner, Paul
Hypertension (Dallas, Tex. 1979), 2010-06, Vol.55 (6), p.1339-1345

10.
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease:...
by Chalmers, John
Hypertension (Dallas, Tex. 1979), 2014-02, Vol.63 (2), p.259-264

11.
Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2012-06, Vol.59 (6), p.1118-1123

12.
Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis
by Lawes, Carlene M M
Hypertension (Dallas, Tex. 1979), 2003-07, Vol.42 (1), p.69-75

13.
Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.852-858

14.
Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE
by Kengne, Andre-Pascal
Hypertension (Dallas, Tex. 1979), 2009-08, Vol.54 (2), p.399-404

15.
Blood Pressure Is a Major Risk Factor for Renal Death: An Analysis of 560 352 Participants From the Asia-Pacific Region
by OʼSeaghdha, Conall M
Hypertension (Dallas, Tex. 1979), 2009-09, Vol.54 (3), p.509-515

16.
Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
by Czernichow, Sébastien
Hypertension (Dallas, Tex. 1979), 2010-05, Vol.55 (5), p.1193-1198

17.
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease
by Campbell, Duncan J
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.69-74
